Immunoprotein Diagnostic Testing Market - Snapshot

Immunoprotein diagnostic testing refers to the diagnostic procedure that determines the level of immunoproteins in the body for the purpose of analyzing certain proteins such as pre-alubumin, immunoglobulin, and many others.  

The global immunoprotein diagnostic testing market is considerably fueled by the presence of innovative technologies.  These technologies are shortening the life cycle of product and are also expanding the boundaries of global immunoprotein diagnostic testing market. These innovations have also created multitude of opportunities for the application of this testing procedure in various sectors of the medical industry.

The global immunoprotein diagnostic testing market could be segmented on the basis of various immunoproteins, which assists in the modulation of immune response. These segments comprise free light chains (FLC), prealbumin, haptoglobin, C-reactive protein (CRP), and complement system proteins of immunoglobulins. Each of these types of proteins has an important role to play in the immune response system. As such, the level of immunoproteins indicates the state of a disease.

Continuous Research and Development Activities to Support Market Growth

The development of the immunoprotein diagnostic testing products is expected to be driven by high prevalence of rheumatoid arthritis, type 2 diabetes, obesity, cancer, cardiovascular disease, and infectious diseases. Increased rate of mortality owing to the prevalence of such chronic diseases has necessitated the need for bringing in rapid diagnosis. In accordance with the data of Centers for Disease Control and Prevention (CDC), various infectious diseases like tuberculosis, malaria, and AIDS is capable of causing almost half of all the deaths in the world.

The major applications of immunoprotein diagnostic testing products are as follows

  • Oncology and endocrinology testing
  • Infectious disease testing
  • Allergy testing
  • Autoimmune testing

In another instance, American Cancer Society projected around 1,806,590 new cancer cases and 606,520 cancer deaths in the United States in the year 2020. Because of such a projection, accurate and fast diagnosis of such chronic diseases is needed to help diminish the high rate of mortality. Immunoprotein diagnostic devices and reagents have proven to be extremely efficacious when it comes to the rapid detection of chronic disorders.

The demand within the global market for immunoprotein diagnostic testing has gained momentum on account of key developments in the field of medical treatment and diagnostics. Immunoprotein, in essence, refer to blood proteins that play a key role in the functioning of the immune system. They endow immunological activity, and hence, are an important component of the human body. Immunoproteins show an abrupt rise in their concentration in the blood as a result of unhealthy immune functioning of the body. This abnormal rise in their concentration can act as a trustable indicator of several diseases or infections in the body. Several research organizations and laboratories have been engaged in the study of immunoproteins and their potential to act as indicators of diseases. This is expected to propel demand within the global market for immunoprotein diagnostic testing and shall open doors for the inflow of commendable revenues into this market.

The rising geriatric population coupled with an all-time high incidence of chronic diseases has given an impetus to the growth of the global market for immunoprotein diagnostic testing. Moreover, the upswing in demand for immunoprotein diagnostic testing can also be attributed to the prevalence of infectious diseases across the globe. Unhygienic living conditions, especially in the underdeveloped regions, have also led to the occurrence of diseases and infections. This has brought the global market for immunoprotein diagnostic testing under the spotlight of attention.

A report by Transparency Market Research (TMR) on the global market for immunoprotein diagnostic testing builds on the key factors that have supported the growth of the market. The report predicts that the global market for immunoprotein diagnostic testing would reach a value of US$15.3 bn by 2019-end, growing at a stellar CAGR over the forecast period from 2013 to 2019.

Chemiluminescence Technology to Lead Other Segments

On the basis of technology used for immunoprotein diagnostic testing, the demand for chemiluminescence assay has been rising at a robust rate as against other technologies. This can be attributed to the sensitivity, easy usage, and wide application scope of this technology. Furthermore, ELISA technologies are up for a chase for greater market share against the aforementioned segment. The radioimmunoassay segment has been tracing a descending graph of growth due to several regulations imposed by the government on the use of radioactive substances. On the basis of application, immunoprotein diagnostic testing can be segmented into oncology, endocrine testing, testing of infectious diseases, allergy testing, toxicology testing, and autoimmune disease testing. Amongst these, oncology testing through immunoprotein diagnosis has attracted the highest demand over the past decade.

North America to Emerge as Regional Market Leader

The US has witnessed a surge in the incidence of chronic diseases over the past few years, and this has necessitated the presence of a robust diagnostic system across the country. Furthermore, medical practitioners in Canada and the US have been making ardent efforts to ensure that immunoprotein testing is given prime impetus. Owing to these factors, the market for immunoprotein diagnostic testing in North America has been expanding at a robust rate over the past few years. Besides this, the markets for immunoprotein diagnostic testing in Europe, the Middle East and Africa (MEA), Latin America, and Asia Pacific (APAC) are also projected to expand their share in the global market share.

Some of the key players in the global market for immunoprotein diagnostic testing are Abcam PLC, Roche, Diasorin, Abbott Laboratories, Enzo Life Sciences, Randox Laboratories, The Binding Site, and Siemens.

Immunoprotein diagnostic testing market is continuously fueled with innovative technologies which are shrinking product life cycle and also expanding the boundaries of market. These innovations have also increased the scope of application in various medical fields. The market for immunoprotein diagnostic testing has been segmented according to various immunoproteins, which help in immune response modulation. These include immunoglobulins, complement system proteins, C-reactive protein (CRP), haptoglobin, prealbumin and free light chains (FLC) of immunoglobulins. Each of these proteins plays a characteristic role in the immune response, and hence the level of these immunoproteins has been considered as an indication of diseased state.
 
Immunoprotein diagnostic testing market has been studied from the perspective of technology platforms such as enzyme linked immunosorbent assay (ELISA), chemiluminescence assay, immunofluorescence assay, immunoturbidity assay, radioimmunoassay, and immunoprotein electrophoresis. Enzyme linked immunosorbent assay is the most widely used technique in the diagnosis of various diseases globally. On the other hand, the market for chemiluminescence assay technology was found to be fastest growing segment owing to broad applications in disease diagnosis, drug testing, oncology and various others.   
 
Further, immunoprotein diagnostic testing market has also been segmented according to application in diagnosis of various diseases. These include infectious disease testing, allergy testing, endocrine testing, oncology testing, toxicology testing, and autoimmune disease testing. Oncology segment is growing rapidly owing to increased disease prevalence and high cost of assay kits. Geographically, the immunoprotein diagnostic testing market has been segmented into four major regions, namely, North America, Europe, Asia-Pacific, and Rest of the World (RoW). Each of these four geographies is further segmented according to assay technologies. Immunoprotein diagnostic testing market report also details market attractiveness analysis for these geographies. The analysis is based on various factors such as current stage of life cycle, market size, customer base, market competition, and annual growth rate.  
 
Immunoprotein diagnostic testing market is subjected to various micro as well as macro economic factors. The impact of these factors has been studied to forecast the future trends. The report also provides detailed Porter’s five forces analysis of the immunoprotein diagnostic testing market. Based on in depth analysis and comprehensive market study, key factors driving and restraining the market have been discussed. Moreover lucrative opportunities and relevant recommendations for sustainable growth in the immunoprotein diagnostic testing market also have been suggested.  Each of the market segments has been analyzed on the basis of current and future market size for the period 2011 to 2019, in terms of revenue (USD million), considering 2011 and 2012 as the base years. The compounded annual growth rate (% CAGR) for each market segment has been provided for the forecast period 2013 to 2019 along with the estimations of market size. An exhaustive heat map analysis of key market players such as Abbott Laboratories, Abcam PLC, Diasorin, Enzo Life Sciences, Randox Laboratories, Roche, Siemens, The Binding Site, and Thermo Fisher Scientific is provided in this report. Each of these key market players are profiled in the report considering parameters such as company overview, financial overview, product portfolio, business strategies and recent developments. 
 
The research methodology was based on primary as well as secondary research. Interviews and discussions with a wide range of key industry participants and opinion leaders revealed real time market scenario. This primary research represented the bulk of the research efforts, which was further supplemented by extensive secondary research. A review of key players’ product literature, annual reports, and press releases supports the market forecast analysis. The 99 pages immunoprotein diagnostic testing market reports described various market dynamics in 30 figures and charts and 9 tables.
Table of Content
 
Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
      1.3.1 Secondary Research
      1.3.2 Primary Research
1.4 List of Abbreviations
1.5 Assumptions and Stipulations
 
Chapter 2 Executive Summary
 
Chapter 3 Global Immunoprotein Diagnostic Testing Market Overview
3.1 Introduction
3.2 Market Trends and Future Outlook
3.3 Market Dynamics
      3.3.1 Drivers
               3.3.1.1 Rising need for quick and accurate disease diagnosis
               3.3.1.2 Technological advancement
               3.3.1.3 Rising demand for preventive healthcare in developing economies
               3.3.1.4 Strong network of distributors across the globe
               3.3.1.5 Commoditization of products
      3.3.2 Restraints
               3.3.2.1 Higher cost of diagnosis
               3.3.2.2 Installed base of traditional ELISA
      3.3.3 Opportunities
               3.3.3.1 Immunochromatography
               3.3.3.2 Research and development
               3.3.3.3 Expansion in emerging economies
3.1 Porter’s Five Force Analysis for the Global Immunoprotein Diagnostic Testing Market
      3.1.1 Bargaining Power of Suppliers
      3.1.2 Bargaining Power of Buyers
      3.1.3 Threat of Substitutes
      3.1.4 Threat of New Entrants
      3.1.5 Competitive Rivalry
3.2 Market Attractiveness Analysis for the Global Immunoprotein Diagnostic Testing Market, by Geography
3.3 Heat Map Analysis: Global Immunoprotein Diagnostic Testing Market
      3.3.1 Methodology
      3.3.2 Heat Map Analysis for the Global Immunoprotein Diagnostic Testing Market, by key players, 2012
 
Chapter 4 Global Immunoprotein Diagnostic Testing Market, by Assay Technology
4.1 Introduction
      4.1.1 Global Immunoprotein Diagnostic Testing Market Revenue, by Assay Technology, 2011 - 2019 (USD Million)
4.2 Radioimmunoassay
      4.2.1 Global Radioimmunoassay Market Revenue, 2011 - 2019 (USD Million)
4.3 Enzyme Based Immunoassay
      4.3.1 Global Enzyme Based Immunoassay Market Revenue, 2011 - 2019 (USD Million)
4.4 Chemiluminescence Assay
      4.4.1 Global Chemiluminescence Assay Market Revenue, 2011 - 2019 (USD Million)
4.5 Immunofluorescence Assay
      4.5.1 Global Immunofluorescence Assay Market Revenue, 2011 - 2019 (USD Million)
4.6 Immunoturbidity Assay
      4.6.1 Global Immunoturbidity Assay Market Revenue, 2011 - 2019 (USD Million)
4.7 Immunoprotein Electrophoresis
      4.7.1 Global Immunoprotein Electrophoresis Assay Market Revenue, 2011 - 2019 (USD Million)
 
Chapter 5 Global Immunoprotein Diagnostic Testing Market, by Immunoprotein Type
5.1 Introduction
      5.1.1 Global Immunoprotein Diagnostic Testing Market Revenue, by Immunoprotein Type, 2011 - 2019 (USD Million)
5.2 Complement System Proteins Diagnostic Tests
      5.2.1 Global Complement System Protein Diagnostic Tests Market Revenue, 2011 - 2019 (USD Million)
5.3 Free Light Chain Diagnostic Tests
      5.3.1 Global Free Light Chain Diagnostic Tests Market Revenue, 2011 - 2019 (USD Million)
5.4 Haptoglobin Diagnostic Tests
      5.4.1 Global Haptoglobin Diagnostic Tests Market Revenue, 2011 - 2019 (USD Million)
5.5 Immunoglobulin Diagnostic Tests
      5.5.1 Global Immunoglobulin Diagnostic Tests Market Revenue, 2011 - 2019 (USD Million)
5.6 Prealbumin Diagnostic Tests
      5.6.1 Global Prealbumin Diagnostic Tests Market Revenue, 2011 - 2019 (USD Million)
5.7 C-Reactive Protein (CRP) Diagnostic Tests
      5.7.1 Global C-Reactive Protein Diagnostic Tests Market Revenue, 2011 - 2019 (USD Million)
 
Chapter 6 Global Immunoprotein Diagnostic Testing Market, by Application
6.1 Introduction
      6.1.1 Global Immunoprotein Diagnostic Testing Market Revenue, by Application, 2011 - 2019 (USD Million)
6.2 Infectious Disease Testing
      6.2.1 Global Infectious Disease Testing Market Revenue, 2011 - 2019 (USD Million)
6.3 Oncology Testing
      6.3.1 Global Oncology Testing Market Revenue, 2011 - 2019 (USD Million)
6.4 Endocrine Testing
      6.4.1 Global Endocrine Testing Market Revenue, 2011 - 2019 (USD Million)
6.5 Toxicology Testing
      6.5.1 Global Toxicology Testing Market Revenue, 2011 - 2019 (USD Million)
6.6 Allergy Testing
      6.6.1 Global Allergy Testing Market Revenue, 2011 - 2019 (USD Million)
6.7 Autoimmune Disease Testing
      6.7.1 Global Autoimmune Disease Testing Market Revenue, 2011 - 2019 (USD Million)
 
Chapter 7 Global Immunoprotein Diagnostic Testing Market, by Geography
7.1 Introduction
      7.1.1 Global Immunoprotein Diagnostic Testing Market Revenue, by Geography, 2011 – 2019 (USD Million)
7.2 North America
      7.2.1 North America Immunoprotein Diagnostic Testing Market Revenue, by Assay Technology, 2011 – 2019 (USD Million)
7.3 Europe
      7.3.1 Europe Immunoprotein Diagnostic Testing Market Revenue, by Assay Technology, 2011 – 2019 (USD Million)
7.4 Asia-Pacific
      7.4.1 Asia-Pacific Immunoprotein Diagnostic Testing Market Revenue, by Assay Technology, 2011 – 2019 (USD Million)
7.5 Rest of the World (RoW)
      7.5.1 Rest of the World Immunoprotein Diagnostic Testing Market Revenue, by Assay Technology, 2011 – 2019 (USD Million)
 
Chapter 8 Recommendations
8.1 Untapped allergy testing market
8.2 Future of oncology testing
8.3 Upgrading to latest technology
 
Chapter 9 Company Profiles
9.1 Abbott Laboratories, Inc.
      9.1.1 Company Overview
      9.1.2 Financial Overview
      9.1.3 Product Portfolio
      9.1.4 Business Strategies
      9.1.5 Recent Developments
9.2 Abcam PLC
      9.2.1 Company Overview
      9.2.2 Financial Overview
      9.2.3 Product Portfolio
      9.2.4 Business Strategies
      9.2.5 Recent Developments
9.3 DiaSorin SPA
      9.3.1 Company Overview
      9.3.2 Financial Overview
      9.3.3 Product Portfolio
      9.3.4 Business Strategies
      9.3.5 Recent Developments
9.4 Enzo Life Sciences, Inc.
      9.4.1 Company Overview
      9.4.2 Financial Overview
      9.4.3 Product Portfolio
      9.4.4 Business Strategies
      9.4.5 Recent Developments
9.5 Fujirebio Diagnostics, Inc.
      9.5.1 Company Overview
      9.5.2 Financial Overview
      9.5.3 Product Portfolio
      9.5.4 Business Strategies
      9.5.5 Recent Developments
9.6 Omega Diagnostics Group PLC
      9.6.1 Company Overview
      9.6.2 Financial Overview
      9.6.3 Product Portfolio
      9.6.4 Business Strategies
      9.6.5 Recent Developments
9.7 Randox Laboratories Ltd.
      9.7.1 Company Overview
      9.7.2 Financial Overview
      9.7.3 Product Portfolio
      9.7.4 Business Strategies
      9.7.5 Recent Developments
9.8 Roche Holding AG
      9.8.1 Company Overview
      9.8.2 Financial Overview
      9.8.3 Product Portfolio
      9.8.4 Business Strategies
      9.8.5 Recent Developments
9.9 Siemens AG
      9.9.1 Company Overview
      9.9.2 Financial Overview
      9.9.3 Product Portfolio
      9.9.4 Business Strategies
      9.9.5 Recent Developments
9.10 The Binding Site Group Ltd.
      9.10.1 Company Overview
      9.10.2 Financial Overview
      9.10.3 Product Portfolio
      9.10.4 Business Strategies
      9.10.5 Recent Developments
9.11 Thermo Fisher Scientific, Inc.
      9.11.1 Company Overview
      9.11.2 Financial Overview
      9.11.3 Product Portfolio
      9.11.4 Business Strategies
      9.11.5 Recent Developments
List of Tables
 
TABLE 1 Market Snapshot: Global Immunoprotein Diagnostic Testing Market
TABLE 2 Global Immunoprotein Diagnostic Testing Market Revenue, by Assay Technology, 2011 - 2019 (USD Million)
TABLE 3 Global Immunoprotein Diagnostic Testing Market Revenue, by Immunoprotein Type, 2011 - 2019 (USD Million)
TABLE 4 Global Immunoprotein Diagnostic Testing Market Revenue, by Application, 2011 - 2019 (USD Million)
TABLE 5 Global Immunoprotein Diagnostic Testing Market Revenue, by Geography, 2011 – 2019 (USD Million)
TABLE 6 North America Immunoprotein Diagnostic Testing Market Revenue, by Assay Technology, 2011 – 2019 (USD Million)
TABLE 7 Europe Immunoprotein Diagnostic Testing Market Revenue, by Assay Technology, 2011 – 2019 (USD Million)
TABLE 8 Asia-Pacific Immunoprotein Diagnostic Testing Market Revenue, by Assay Technology, 2011 – 2019 (USD Million)
TABLE 9 Rest of the World Immunoprotein Diagnostic Testing Market Revenue, by Assay Technology, 2011 – 2019 (USD Million)

List of Figures

 

FIG. 1 Global Immunoprotein Diagnostic Testing Market – Market Segmentation

FIG. 2 Global Immunoprotein Diagnostic Testing Market Revenue, 2011-2019 (USD Million)

FIG. 3 Porter’s Five Force Analysis: Global Immunoprotein Diagnostic Testing Market

FIG. 4 Market Attractiveness Analysis: Global Immunoprotein Diagnostic Testing Market, by Geography

FIG. 5 Heat Map Analysis: Global Immunoprotein Diagnostic Testing Market, by Key Players (2012)

FIG. 6 Global Radioimmunoassay Market Revenue, 2011 - 2019 (USD Million)

FIG. 7 Global Enzyme Based Immunoassay Market Revenue, 2011 – 2019 (USD Million)

FIG. 8 Global Chemiluminescence Assay Market Revenue, 2011 – 2019 (USD Million)

FIG. 9 Global Immunofluorescence Assay Market  Revenue, 2011 – 2019 (USD Million)

FIG. 10 Global Immunoturbidity Assay Market Revenue, 2011 – 2019 (USD Million)

FIG. 11 Global Immunoprotein Electrophoresis Assay Market Revenue, 2011 – 2019 (USD Million)

FIG. 12 Global Complement System Protein Diagnostic Tests Market Revenue, 2011 - 2019 (USD Million)

FIG. 13 Global Free Light Chain Diagnostic Tests Market Revenue, 2011 - 2019 (USD Million)

FIG. 14 Global Haptoglobin Diagnostic Tests Market Revenue, 2011 - 2019 (USD Million)

FIG. 15 Global Immunoglobulin Diagnostic Tests Market Revenue, 2011 - 2019 (USD Million)

FIG. 16 Global Prealbumin Dagnostic Tests Market Revenue, 2011 - 2019 (USD Million)

FIG. 17 Global C-Reactive Protein Diagnostic Tests Market Revenue, 2011 - 2019 (USD Million)

FIG. 18 Global Infectious Disease Testing Market Revenue, 2011 - 2019 (USD Million)

FIG. 19 Global Oncology Testing Market Revenue, 2011 - 2019 (USD Million)

FIG. 20 Global Endocrine Testing Market Revenue, 2011 - 2019 (USD Million)

FIG. 21 Global Toxicology Testing Market Revenue, 2011 - 2019 (USD Million)

FIG. 22 Global Allergy Testing Market Revenue, 2011 - 2019 (USD Million)

FIG. 23 Global Autoimmune Disease Testing Market Revenue, 2011 - 2019 (USD Million)

FIG. 24 Abbott Laboratories, Inc.: Annual Revenue, 2010 – 2012 (USD Million)

FIG. 25 Abcam PLC: Annual Revenue, 2010 – 2012 (USD Million)

FIG. 26 DiaSorin SPA: Annual Revenue, 2010 – 2012 (USD Million)

FIG. 27 Omega Diagnostics Group PLC: Annual Revenue, 2010 – 2012 (USD Million)

FIG. 28 Roche Holding AG: Annual Revenue, 2010 – 2012 (USD Million)

FIG. 29 Siemens AG (Healthcare Segment): Annual Revenue, 2010 – 2012 (USD Million)

FIG. 30 Thermo Fisher Scientific, Inc.: Annual Revenue, 2010 – 2012 (USD Million)

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Immunoprotein Diagnostic Testing Market